contract development and manufacturing organisation

  1. H

    Sai Parenteral IPO: Stock Performance at Market Debut

    Sai Parenteral Shares List at Premium Despite Weak Market Sentiment New Delhi, April 2: Shares of Sai Parenteral, a diversified pharmaceutical formulation company, made a positive stock market debut on Thursday, listing at a premium of over 3 percent compared to its issue price, even as broader...
  2. H

    Sai Parenteral’s IPO Price Band Set at ₹372 to ₹392 per Share, Targets ₹285 Crore Fresh Issue

    Sai Parenteral’s IPO Price Band Set at ₹372 to ₹392 per Share, Targets ₹285 Crore Fresh Issue Company Files RHP with SEBI and Stock Exchanges Sai Parenteral’s Ltd, a diversified pharmaceutical formulation company, has announced the price band for its upcoming Initial Public Offering, setting it...
Back
Top